Susan L. Rosenkranz

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial”.

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(20)30770-2

N/A

4.9DataRank · unranked

124 citations

Susan L. Rosenkranz, Francesca Conradie, Laura Moran, Richard Hafner, Florian von Groote-Bidlingmaier +26 more

High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202311-2004oc

N/A

0.741DataRank · unranked

13 citations

Elisa H. Ignatius, Veronique de Jager, Caryn M. Upton, Soyeon Kim, Ashley McKhann +14 more

Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention

Clinical Infectious Diseases(2024)10.1093/cid/ciae183

N/A

0.372DataRank · unranked

6 citations

Yoninah Cramer, Marjorie Z. Imperial, Susan L. Rosenkranz, Anchalee Avihingsanon, Roberto C. Arduino +7 more

Comparison of Once‐Daily versus Twice‐Daily Combination Antiretroviral Therapy in Treatment‐Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48‐Week Randomized Controlled Trial

UNC Libraries(2020)10.17615/msnd-sd43

N/A

0DataRank · unranked

0 citations

Robert A. Gross, Camlin Tierney, Angela D. M. Kashuba, Elaine Ferguson, Christina M. Lalama +10 more

Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2685

N/A

0DataRank · unranked

20 citations

Mats O. Karlsson, Susan L. Rosenkranz, Yoninah Cramer, Justin Shenje, Caryn M. Upton +6 more

Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac188

N/A

0DataRank · unranked

8 citations

Maxwell Chirehwa, Elisa H. Ignatius, Richard Court, Xin Sun, Laura Moran +13 more